Quote

The world’s big pharmaceutical companies are cutting back their research into treatment for Alzheimer’s, after being hit by the failure of a number of high profile, and expensive, drugs trials. Sir John Bell, Life Sciences Champion for the government, and Stephen Whitehead, head of the Association of the British Pharmaceutical Industry discuss why it is proving so hard to find something that works.

BBC Radio4 Today: Thursday 20th September 07:50 BSTOur Paper on Alzheimers Disease

Quote

Statins for all? (BMJ Extract)
An epidemiologist’s call for all healthy adults over 50 to take statins was uncritically reinforced by the media without proper discussion of side effects. A problem for primary care doctors is that even rare side effects become common when millions of low risk patients are treated with statins……………………….As for evidence that high risk patients are deciding not to take statins because of a perceived risk of side e‹ ects, this seems to be based on anecdote, and my own anecdote is also that many patients decline to take statins, saying that the side effects are unacceptable.
The arguments for giving statins to a whole population need to be made equally in forms of absolute risk; we must be fair about potential side effects, including the association with diabetes; and crucially we must also be clear that improving population health should not simply
be made the work of drug companies.

Margaret McCartney general practitioner, Glasgow
References are in the version on bmj.com.
BMJ 2012;345:e6044

Image

lizwainwright:

The Girl who wasn’t Good Enough is the first of The Lynda Collins Trilogy.

Liz is currently writing books 2 and 3. The original Book 3 was the first of the books to be written and it was suggested that readers would want to know where Lynda Collins’ background. The writing of books 1 & 2 will cause a major revision of book 3. Liz is very enthusiastic about the whole project. Reactions to book 1 have exceeded expectations.

Liz’s Radio Drama & Stage Plays are also available in paperback.

Link

This is a new table that brings the rare earths in from the cold. In particular, it predicts a dramatic role for thulium (a hitherto obscure element) as between silver and gold in group I. The paper thus ended with a prediction and a hypothesis to test: that there exists monovalent thulium, either Tm[+1] analogous to aurous oxide or Tm[-1] analogous to caesium auride.New Periodic Table

E. G. Marks and J. A. Marks

A refreshing look at the Periodic Table

Link

“The Obesity Epidemic by Zoë Harcombe: What caused it? How can we stop it?” does what it says in the title – it answers those two critical questions. It takes you on the journey that the author, Zoë Harcombe went on to answer those The Obesity Epidemicquestions and hopefully it will shock you as much as it shocked her.

ISBN: 978-1-907797-00-2

The Obesity Epidemic